Last additions - Macular Degeneration - Age Related, Myopic, Choroidal Neovascular Membranes
|
Myopic CNVM Left Eye99 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye119 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye133 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye133 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye131 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye145 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye165 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion116 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion116 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion96 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion103 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion93 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion120 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion119 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion111 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion109 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion89 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion113 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion128 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion111 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion107 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion117 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion125 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion95 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion126 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion101 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion96 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion90 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion118 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion91 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion98 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye176 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye119 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye88 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye89 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye92 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye119 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye88 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye123 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye123 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye117 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye103 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye91 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye103 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye126 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye135 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye109 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye77 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye79 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye111 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye85 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye102 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye113 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye118 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye103 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye130 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye114 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye110 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye109 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
Large Hyper-reflective drusen in age-related macular degeneration215 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration226 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration196 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration182 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration211 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration210 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration210 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration200 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration221 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Non exudative MNV162 viewsSep 18, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion212 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion200 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion194 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion181 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion184 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion214 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion201 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion197 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion235 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years196 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years215 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years182 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years186 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years182 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years210 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years195 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years175 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years187 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years169 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years178 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years171 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years190 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years182 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years161 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years155 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years190 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years221 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years175 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years214 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years204 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years224 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
| 2694 files on 27 page(s) |
 |
3 | |
|
|
|
|
|
|
|
|
